Andre Tartar
Director/Board Member chez GENOWAY
Profil
Andre Tartar was the founder of Eurofins-Cerep SA, founded in 1989, where he held the title of Chief Scientific Officer from 1996 to 1998, and Institut Pasteur de Lille, founded in 1986, where he held the title of Chairman-Bioorganic Chemistry Department from 1986 to 1996.
He is currently a Director at genOway SA and a Professor at Université de Lille II since 1981.
Dr. Tartar's former jobs include Chemistry Director at Ferring Research Institute, Inc. from 1999 to 2004, Director at ORPHELIA Pharma SAS, Principal at Diverchim SA, and President at Société de Chimie Therapeutique.
Postes actifs de Andre Tartar
Sociétés | Poste | Début |
---|---|---|
GENOWAY | Director/Board Member | - |
Université de Lille II | Corporate Officer/Principal | 01/01/1981 |
Anciens postes connus de Andre Tartar
Sociétés | Poste | Fin |
---|---|---|
Ferring Research Institute, Inc.
Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2004 |
EUROFINS CEREP | Founder | 01/01/1998 |
Institut Pasteur de Lille | Founder | 01/01/1996 |
Société de Chimie Therapeutique
Société de Chimie Therapeutique Miscellaneous Commercial ServicesCommercial Services Société de Chimie Thérapeutique is a French Medchem Society based in Malabry, France. The society is administered by an Executive Board and provides for the re-election or replacement of its members through a call for nominations process. The society also supports young researchers by providing a prestigious prize entitled “Prix d’Encouragement à la Recherche en Chimie Thérapeutique” sponsored by Institut de Recherche Servier, which is devoted to junior European scientists. The society complies with the law of July 10, 2012, on various provisions relating to electronic communications and transposes the European Directive No. 2009/136/EC of the European Parliament and of the Council of November 25, 2009, regarding the new constraints and obligations of publishers and owners of websites on information. The call for 2023 Young Medicinal Chemist in Industry Award is now closed, and the new call will be announced in November 2023. | President | - |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
EUROFINS CEREP | Commercial Services |
GENOWAY | Health Technology |
Entreprise privées | 5 |
---|---|
Institut Pasteur de Lille | Commercial Services |
Ferring Research Institute, Inc.
Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Retail Trade |
Diverchim SA
Diverchim SA Pharmaceuticals: MajorHealth Technology Diverchim SA provides pharmaceutical services. It offers computer aided drug, medicinal chemistry, immunochemistry, chemical development, analytical services, and discovery. The firm products are building blocks and screening, collection, and new tools for asymmetric catalysis. The company was founded by Jean Louis Brayer and Benoit Folleas in March 2001 and is headquartered in Roissy-en-France, France. | Health Technology |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France. | Health Technology |
Société de Chimie Therapeutique
Société de Chimie Therapeutique Miscellaneous Commercial ServicesCommercial Services Société de Chimie Thérapeutique is a French Medchem Society based in Malabry, France. The society is administered by an Executive Board and provides for the re-election or replacement of its members through a call for nominations process. The society also supports young researchers by providing a prestigious prize entitled “Prix d’Encouragement à la Recherche en Chimie Thérapeutique” sponsored by Institut de Recherche Servier, which is devoted to junior European scientists. The society complies with the law of July 10, 2012, on various provisions relating to electronic communications and transposes the European Directive No. 2009/136/EC of the European Parliament and of the Council of November 25, 2009, regarding the new constraints and obligations of publishers and owners of websites on information. The call for 2023 Young Medicinal Chemist in Industry Award is now closed, and the new call will be announced in November 2023. | Commercial Services |